DROXIA is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Hydroxyurea.
| Product ID | 0003-6336_16f97dab-3e4a-453e-b3b8-f593a15c248e |
| NDC | 0003-6336 |
| Product Type | Human Prescription Drug |
| Proprietary Name | DROXIA |
| Generic Name | Hydroxyurea |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2009-06-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA016295 |
| Labeler Name | E.R. Squibb & Sons, L.L.C. |
| Substance Name | HYDROXYUREA |
| Active Ingredient Strength | 300 mg/1 |
| Pharm Classes | Antimetabolite [EPC],Urea [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2015-07-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA016295 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-07-16 |
| Ingredient | Strength |
|---|---|
| HYDROXYUREA | 300 mg/1 |
| SPL SET ID: | 740e054b-faac-7c27-f06d-a56efb699355 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0003-6335 | DROXIA | HYDROXYUREA |
| 0003-6336 | DROXIA | HYDROXYUREA |
| 0003-6337 | DROXIA | HYDROXYUREA |
| 0003-0830 | HYDREA | HYDROXYUREA |
| 0093-0882 | HYDROXYUREA | Hydroxyurea |
| 0555-0882 | HYDROXYUREA | Hydroxyurea |
| 0904-6939 | Hydroxyurea | Hydroxyurea |
| 10135-702 | Hydroxyurea | Hydroxyurea |
| 24535-0831 | Hydroxyurea | Hydroxyurea |
| 42291-321 | HYDROXYUREA | Hydroxyurea |
| 49884-724 | Hydroxyurea | Hydroxyurea |
| 55154-3554 | Hydroxyurea | Hydroxyurea |
| 55154-7143 | Hydroxyurea | Hydroxyurea |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DROXIA 75318230 2222043 Live/Registered |
BRISTOL-MYERS SQUIBB COMPANY 1997-07-02 |